पूर्व छात्र https://www.nciindia.gov.in/index.php/2014-11-25-11-26-37/280-cru 2025-12-19T12:13:45+05:30 Clinical Research Unit 2020-08-20T16:03:17+05:30 2020-08-20T16:03:17+05:30 https://www.nciindia.gov.in/index.php/hi/cru_cru-activities/other-activities_cru Aman_CF gupta.amn@gmail.com <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p style="text-align: center;"><span style="font-family: Cambria; font-size: medium;"><strong>Other activities</strong></span></p> <ol start="1"> <li style="text-align: justify;"><span style="font-family: Cambria; font-size: small;">In the wake of Covid-19 pandemic, fast track intramural grant was announced and over 80 proposals were received. The proposals were reviewed and the shortlisted proposals were approved for funding.<br /> Out of these, 9 clinical observational studies were having similarities, so it was decided to develop common Case Record Form (CRF) for investigators for the multiple sites where Covid-19 patients are being admitted. The data of common CRF is being stored on AIIMS server and different components for each patients can be filled by at different time points and from multiple locations as required.</span></li> <ol style="list-style-type: lower-alpha;"> <li style="text-align: justify;"><span style="font-family: Cambria; font-size: small;">CRU prepared the common informed consent documents and developed the online case record form in collaboration with the Principal Investigators of the nine observational studies. These studies also required a common consent form, so that in each area the first team in patients care can take consent for all components of the data related to the patients.</span></li> <li style="text-align: justify;"><span style="font-family: Cambria; font-size: small;">The Common CRF and a common Consent Form was designed and ethical approval was obtained for the nine PIs.</span></li> <li style="text-align: justify;"><span style="font-family: Cambria; font-size: small;">The software for Common CRF has been developed, pre tested and been made functional for all teams working for Covid-19 related research.</span></li> </ol></ol></div></div> <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p style="text-align: center;"><span style="font-family: Cambria; font-size: medium;"><strong>Other activities</strong></span></p> <ol start="1"> <li style="text-align: justify;"><span style="font-family: Cambria; font-size: small;">In the wake of Covid-19 pandemic, fast track intramural grant was announced and over 80 proposals were received. The proposals were reviewed and the shortlisted proposals were approved for funding.<br /> Out of these, 9 clinical observational studies were having similarities, so it was decided to develop common Case Record Form (CRF) for investigators for the multiple sites where Covid-19 patients are being admitted. The data of common CRF is being stored on AIIMS server and different components for each patients can be filled by at different time points and from multiple locations as required.</span></li> <ol style="list-style-type: lower-alpha;"> <li style="text-align: justify;"><span style="font-family: Cambria; font-size: small;">CRU prepared the common informed consent documents and developed the online case record form in collaboration with the Principal Investigators of the nine observational studies. These studies also required a common consent form, so that in each area the first team in patients care can take consent for all components of the data related to the patients.</span></li> <li style="text-align: justify;"><span style="font-family: Cambria; font-size: small;">The Common CRF and a common Consent Form was designed and ethical approval was obtained for the nine PIs.</span></li> <li style="text-align: justify;"><span style="font-family: Cambria; font-size: small;">The software for Common CRF has been developed, pre tested and been made functional for all teams working for Covid-19 related research.</span></li> </ol></ol></div></div> Clinical Research Unit 2020-08-20T13:48:31+05:30 2020-08-20T13:48:31+05:30 https://www.nciindia.gov.in/index.php/hi/cru_event Aman_CF gupta.amn@gmail.com <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research} <p> </p> </div> <div class="content-right"><span style="text-decoration: underline;"><span style="font-size: medium;"><strong>Events</strong></span></span> <p> </p> <div align="center"> <table> <tbody> <tr> <td colspan="2"><span style="font-family: Cambria; font-size: small;"><strong>DBT Wellcome Trust grantsmanship workshop series: Glimpses</strong></span></td> </tr> <tr> <td colspan="2"> <p align="center"><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/1.jpg" border="0" width="280" height="380" /></p> </td> </tr> <tr> <td width="282"><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/2.jpg" border="0" width="280" height="280" /></td> <td><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/3.jpg" border="0" width="280" height="280" /></td> </tr> <tr> <td width="282"><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/4.jpg" border="0" width="280" height="280" /></td> <td><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/5.jpg" border="0" width="280" height="280" /></td> </tr> <tr> <td width="282"><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/6.jpg" border="0" width="280" height="280" /></td> <td> </td> </tr> </tbody> </table> </div> </div></div> <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research} <p> </p> </div> <div class="content-right"><span style="text-decoration: underline;"><span style="font-size: medium;"><strong>Events</strong></span></span> <p> </p> <div align="center"> <table> <tbody> <tr> <td colspan="2"><span style="font-family: Cambria; font-size: small;"><strong>DBT Wellcome Trust grantsmanship workshop series: Glimpses</strong></span></td> </tr> <tr> <td colspan="2"> <p align="center"><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/1.jpg" border="0" width="280" height="380" /></p> </td> </tr> <tr> <td width="282"><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/2.jpg" border="0" width="280" height="280" /></td> <td><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/3.jpg" border="0" width="280" height="280" /></td> </tr> <tr> <td width="282"><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/4.jpg" border="0" width="280" height="280" /></td> <td><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/5.jpg" border="0" width="280" height="280" /></td> </tr> <tr> <td width="282"><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/6.jpg" border="0" width="280" height="280" /></td> <td> </td> </tr> </tbody> </table> </div> </div></div> Clinical Research Unit 2020-08-20T13:03:11+05:30 2020-08-20T13:03:11+05:30 https://www.nciindia.gov.in/index.php/hi/cru_cru-support-for-different-stages-of-clinical-research Aman_CF gupta.amn@gmail.com <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <table style="border-collapse: collapse; width: 100%;" border="0"> <tbody> <tr> <td style="text-align: center;"><span style="font-family: cambria, cambria; font-size: small;"><strong><span style="font-size: large;">CRU support for different stages of clinical research</span> </strong></span></td> </tr> <tr> <td><span style="font-family: cambria, cambria; font-size: small;">CRU support for different stages of clinical research A fully operational CRU shall have the necessary expertise in the design and conduct of various types of studies and multiple activities</span></td> </tr> <tr> <td><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/CRU support-20-8-20.jpg" border="0" width="643" height="573" /></td> </tr> </tbody> </table> </div></div> <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <table style="border-collapse: collapse; width: 100%;" border="0"> <tbody> <tr> <td style="text-align: center;"><span style="font-family: cambria, cambria; font-size: small;"><strong><span style="font-size: large;">CRU support for different stages of clinical research</span> </strong></span></td> </tr> <tr> <td><span style="font-family: cambria, cambria; font-size: small;">CRU support for different stages of clinical research A fully operational CRU shall have the necessary expertise in the design and conduct of various types of studies and multiple activities</span></td> </tr> <tr> <td><img src="images/pdf/Departments_Centers/CRU_clinical Research Unit/CRU support-20-8-20.jpg" border="0" width="643" height="573" /></td> </tr> </tbody> </table> </div></div> Clinical Research Unit 2020-08-20T12:55:45+05:30 2020-08-20T12:55:45+05:30 https://www.nciindia.gov.in/index.php/hi/cru_cru-activities/dbt-wellcome-trust-grantsmanship-workshop-serie_cru Aman_CF gupta.amn@gmail.com <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p align="center"><span style="font-family: Cambria; font-size: medium;"><strong> CRU activities</strong></span></p> <div class="content-right"> <p align="justify"><span style="font-family: Cambria; font-size: small;"><strong>DBT Wellcome Trust grantsmanship workshop series</strong></span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">As a first exercise, the CRU planned and initiated the grantsmanship workshop series to foster interest and enthusiasm among the faculty, scientists, and residents to apply for the prestigious research fellowships of the DBT Wellcome Trust. </span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">1.1. <strong>The first sensitization workshop </strong>was conducted on 6 Nov 2019 at the Dr Ramalingaswami Board Room, AIIMS. The Director, AIIMS, Dr Randeep Guleria, chaired the session; Dr. Shahid Jameel, CEO of Wellcome Trust/DBT India Alliance and Prof. Usha Menon from the Clinical Trials Unit, Medical Research Council, UCL London joined as speakers. About 200 participants ranging from faculty, scientists, research staff, and PhD and postgraduate students from various disciplines participated in the activity. </span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">1.2. <strong>The second Grantsmanship Workshop</strong> was planned for aspirants for concept proposal for the Wellcome Trust/ DBT India Alliance Clinical and Public Health Fellowships. A total of 38 faculty members and two (02) senior residents submitted the concept notes to the research section, which were reviewed by three of the lead mentors. Of these, 23 were selected for the mentoring workshop held on 15-16 Jan 2020. There were four lead mentors (Dr Usha Menon, UCL, London; Dr Shinjini Bhatnagar, THSTI; Dr Madhulika Kabra, AIIMS and Dr V Sreenivas, AIIMS) and 2-3 in-house subject experts for each proposal. </span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">1.3. <strong>The third workshop of Grantsmanship Workshop series</strong> was held online (Zoom) on 27-28, Apr 2020, for the 17 proposals that cleared Stage-I and were invited for full/detailed proposal submission by India Alliance. Of the 17 final proposals submitted, 11 were reviewed by the lead mentors and subject experts besides online mentoring and remaining took help from the mentors by electronic methods. </span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">1.4. Of the 18 concept notes submitted, 17 cleared Stage-I and all the 17 candidates submitted full/detailed proposal for the stage-II evaluation of the India Alliance for Clinical and Public health Fellowships in April 2020.</span></p> <p align="justify"> </p> </div> </div></div> <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p align="center"><span style="font-family: Cambria; font-size: medium;"><strong> CRU activities</strong></span></p> <div class="content-right"> <p align="justify"><span style="font-family: Cambria; font-size: small;"><strong>DBT Wellcome Trust grantsmanship workshop series</strong></span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">As a first exercise, the CRU planned and initiated the grantsmanship workshop series to foster interest and enthusiasm among the faculty, scientists, and residents to apply for the prestigious research fellowships of the DBT Wellcome Trust. </span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">1.1. <strong>The first sensitization workshop </strong>was conducted on 6 Nov 2019 at the Dr Ramalingaswami Board Room, AIIMS. The Director, AIIMS, Dr Randeep Guleria, chaired the session; Dr. Shahid Jameel, CEO of Wellcome Trust/DBT India Alliance and Prof. Usha Menon from the Clinical Trials Unit, Medical Research Council, UCL London joined as speakers. About 200 participants ranging from faculty, scientists, research staff, and PhD and postgraduate students from various disciplines participated in the activity. </span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">1.2. <strong>The second Grantsmanship Workshop</strong> was planned for aspirants for concept proposal for the Wellcome Trust/ DBT India Alliance Clinical and Public Health Fellowships. A total of 38 faculty members and two (02) senior residents submitted the concept notes to the research section, which were reviewed by three of the lead mentors. Of these, 23 were selected for the mentoring workshop held on 15-16 Jan 2020. There were four lead mentors (Dr Usha Menon, UCL, London; Dr Shinjini Bhatnagar, THSTI; Dr Madhulika Kabra, AIIMS and Dr V Sreenivas, AIIMS) and 2-3 in-house subject experts for each proposal. </span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">1.3. <strong>The third workshop of Grantsmanship Workshop series</strong> was held online (Zoom) on 27-28, Apr 2020, for the 17 proposals that cleared Stage-I and were invited for full/detailed proposal submission by India Alliance. Of the 17 final proposals submitted, 11 were reviewed by the lead mentors and subject experts besides online mentoring and remaining took help from the mentors by electronic methods. </span></p> <p align="justify"><span style="font-family: Cambria; font-size: small;">1.4. Of the 18 concept notes submitted, 17 cleared Stage-I and all the 17 candidates submitted full/detailed proposal for the stage-II evaluation of the India Alliance for Clinical and Public health Fellowships in April 2020.</span></p> <p align="justify"> </p> </div> </div></div> Clinical Research Unit 2020-08-20T12:53:21+05:30 2020-08-20T12:53:21+05:30 https://www.nciindia.gov.in/index.php/hi/cru_meet-the-team Aman_CF gupta.amn@gmail.com <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right" style="text-align: left;"><span style="font-family: Cambria; font-size: medium;"><strong>Meet the Team</strong></span> <p><span style="font-family: Cambria; font-size: small;">Dr. Chitra Sarkar, Dean, Research</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Vineet Ahuja, Associate-Dean, Research</span></p> <p><span style="font-family: Cambria; font-size: small;"><strong><span style="font-size: medium;">Working Committee</span> </strong></span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Sameer Bakshi, Deptt. of Medical Oncology</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Vijay Prakash Mathur, Centre for Dental Education and Research</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Rakesh Lodha, Deptt. of Pediatrics</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Sumit Malhotra, Centre for Community Medicine </span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Pooja Gupta, Deptt. of Pharmacology</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. M Jeeva Sankar, Deptt. of Pediatrics</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Saurabh Kedia, Deptt. of Gastroenterology</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. M. Kalaivani, Deptt. of Biostatistics</span></p> </div></div> <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right" style="text-align: left;"><span style="font-family: Cambria; font-size: medium;"><strong>Meet the Team</strong></span> <p><span style="font-family: Cambria; font-size: small;">Dr. Chitra Sarkar, Dean, Research</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Vineet Ahuja, Associate-Dean, Research</span></p> <p><span style="font-family: Cambria; font-size: small;"><strong><span style="font-size: medium;">Working Committee</span> </strong></span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Sameer Bakshi, Deptt. of Medical Oncology</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Vijay Prakash Mathur, Centre for Dental Education and Research</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Rakesh Lodha, Deptt. of Pediatrics</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Sumit Malhotra, Centre for Community Medicine </span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Pooja Gupta, Deptt. of Pharmacology</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. M Jeeva Sankar, Deptt. of Pediatrics</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. Saurabh Kedia, Deptt. of Gastroenterology</span></p> <p><span style="font-family: Cambria; font-size: small;">Dr. M. Kalaivani, Deptt. of Biostatistics</span></p> </div></div> Clinical Research Unit 2020-08-20T12:48:48+05:30 2020-08-20T12:48:48+05:30 https://www.nciindia.gov.in/index.php/hi/cru_core-expertise-of-the-clinical-research-unit-cru Aman_CF gupta.amn@gmail.com <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p class="MsoNormal" style="text-align: center;"><span style="font-size: large;"><strong><span style="font-family: Cambria,serif; color: black;"> Core expertise of the Clinical Research Unit (CRU)</span></strong></span></p> <div align="center"> <table class="MsoTableGrid" style="border-collapse: collapse;" border="1" cellspacing="0" cellpadding="0"> <tbody> <tr style="height: 12.65pt;"> <td style="width: 427.45pt; height: 12.65pt; border: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm;" colspan="2" valign="top" width="570"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: black;" lang="EN-US"> Phase I: Planning</span></strong></span></p> </td> </tr> <tr style="height: 134.55pt;"> <td style="width: 135.6pt; height: 134.55pt; border-left: 1.0pt solid windowtext; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #222A35;" valign="top" width="181"> <p class="MsoListParagraphCxSpFirst" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Grant preparation</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Study hypothesis</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Study Design</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Sample Size</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Study Protocol</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Feasibility</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Outcomes</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Outcome development</span></span></p> <p class="MsoListParagraphCxSpLast" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Costing</span></span></p> </td> <td style="width: 291.85pt; height: 134.55pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #ACB9CA;" valign="top" width="389"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Translating research idea into a feasible study hypothesis</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Support for literature review – conduct of systematic reviews and meta-analysis</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Interdepartmental liaison/ collaborations</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Protocol writing and study methodological aspects</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Budgeting </span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Statistical Analysis Plan </span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Registration of protocols and preparing documents for funding agencies </span></p> </td> </tr> </tbody> </table> </div> <p class="MsoNormal"><strong><span style="font-family: Cambria,serif; color: black;"> </span></strong></p> <div align="center"> <table class="MsoTableGrid" style="border-collapse: collapse;" border="1" cellspacing="0" cellpadding="0"> <tbody> <tr style="height: 10.3pt;"> <td style="width: 15.0cm; height: 10.3pt; border: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm;" colspan="5" valign="top" width="567"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: black;" lang="EN-US"> Phase II: Study Conduct</span></strong></span></p> </td> </tr> <tr style="height: 11.15pt;"> <td style="width: 83.3pt; height: 11.15pt; border-left: 1.0pt solid windowtext; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #222A35;" valign="top" width="111"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Set-up</span></strong></span></p> </td> <td style="width: 83.3pt; height: 11.15pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #1F3864;" valign="top" width="111"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Conduct</span></strong></span></p> </td> <td style="width: 78.4pt; height: 11.15pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #222A35;" valign="top" width="105"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Analysis</span></strong></span></p> </td> <td style="width: 106.45pt; height: 11.15pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #1F3864;" valign="top" width="142"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Report</span></strong></span></p> </td> <td style="width: 73.8pt; height: 11.15pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #222A35;" valign="top" width="98"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Publication</span></strong></span></p> </td> </tr> <tr style="height: 142.5pt;"> <td style="width: 83.3pt; height: 142.5pt; border-left: 1.0pt solid windowtext; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #ACB9CA;" valign="top" width="111"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Consent Form</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Protocol development</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Case report Forms</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Database design</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Randomization</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Ethical approval</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Administrative approvals</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Logistics</span></p> </td> <td style="width: 83.3pt; height: 142.5pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #B4C6E7;" valign="top" width="111"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Trial/Study management</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Coordination</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Randomization</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Adverse event management</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Monitoring</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Trial meetings</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Quality assurance</span></p> </td> <td style="width: 78.4pt; height: 142.5pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #ACB9CA;" valign="top" width="105"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Statistical analysis plan</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Data validation</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Programming and analysis</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US">  </span></p> </td> <td style="width: 106.45pt; height: 142.5pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #B4C6E7;" valign="top" width="142"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Study Reports</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Data interpretation</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Trial/Study Steering Committee reports</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US">  </span></p> </td> <td style="width: 73.8pt; height: 142.5pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #ACB9CA;" valign="top" width="98"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Advice and consulting</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> drafting aspects of the publication</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US">  </span></p> </td> </tr> </tbody> </table> </div>  </div></div> <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p class="MsoNormal" style="text-align: center;"><span style="font-size: large;"><strong><span style="font-family: Cambria,serif; color: black;"> Core expertise of the Clinical Research Unit (CRU)</span></strong></span></p> <div align="center"> <table class="MsoTableGrid" style="border-collapse: collapse;" border="1" cellspacing="0" cellpadding="0"> <tbody> <tr style="height: 12.65pt;"> <td style="width: 427.45pt; height: 12.65pt; border: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm;" colspan="2" valign="top" width="570"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: black;" lang="EN-US"> Phase I: Planning</span></strong></span></p> </td> </tr> <tr style="height: 134.55pt;"> <td style="width: 135.6pt; height: 134.55pt; border-left: 1.0pt solid windowtext; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #222A35;" valign="top" width="181"> <p class="MsoListParagraphCxSpFirst" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Grant preparation</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Study hypothesis</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Study Design</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Sample Size</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Study Protocol</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Feasibility</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Outcomes</span></span></p> <p class="MsoListParagraphCxSpMiddle" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Outcome development</span></span></p> <p class="MsoListParagraphCxSpLast" style="text-align: justify; text-indent: -18.0pt; margin-left: 18.0pt;"><span style="font-size: small;"><span style="font-family: Symbol; color: white;" lang="EN-US">·<span style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman'; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-language-override: normal; font-feature-settings: normal; font-variation-settings: normal;">         </span></span> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Costing</span></span></p> </td> <td style="width: 291.85pt; height: 134.55pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #ACB9CA;" valign="top" width="389"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Translating research idea into a feasible study hypothesis</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Support for literature review – conduct of systematic reviews and meta-analysis</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Interdepartmental liaison/ collaborations</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Protocol writing and study methodological aspects</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Budgeting </span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Statistical Analysis Plan </span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> •Registration of protocols and preparing documents for funding agencies </span></p> </td> </tr> </tbody> </table> </div> <p class="MsoNormal"><strong><span style="font-family: Cambria,serif; color: black;"> </span></strong></p> <div align="center"> <table class="MsoTableGrid" style="border-collapse: collapse;" border="1" cellspacing="0" cellpadding="0"> <tbody> <tr style="height: 10.3pt;"> <td style="width: 15.0cm; height: 10.3pt; border: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm;" colspan="5" valign="top" width="567"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: black;" lang="EN-US"> Phase II: Study Conduct</span></strong></span></p> </td> </tr> <tr style="height: 11.15pt;"> <td style="width: 83.3pt; height: 11.15pt; border-left: 1.0pt solid windowtext; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #222A35;" valign="top" width="111"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Set-up</span></strong></span></p> </td> <td style="width: 83.3pt; height: 11.15pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #1F3864;" valign="top" width="111"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Conduct</span></strong></span></p> </td> <td style="width: 78.4pt; height: 11.15pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #222A35;" valign="top" width="105"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Analysis</span></strong></span></p> </td> <td style="width: 106.45pt; height: 11.15pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #1F3864;" valign="top" width="142"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Report</span></strong></span></p> </td> <td style="width: 73.8pt; height: 11.15pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #222A35;" valign="top" width="98"> <p class="MsoNormal"><span style="font-size: small;"><strong> <span style="font-family: Cambria,serif; color: white;" lang="EN-US"> Publication</span></strong></span></p> </td> </tr> <tr style="height: 142.5pt;"> <td style="width: 83.3pt; height: 142.5pt; border-left: 1.0pt solid windowtext; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #ACB9CA;" valign="top" width="111"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Consent Form</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Protocol development</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Case report Forms</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Database design</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Randomization</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Ethical approval</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Administrative approvals</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Logistics</span></p> </td> <td style="width: 83.3pt; height: 142.5pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #B4C6E7;" valign="top" width="111"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Trial/Study management</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Coordination</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Randomization</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Adverse event management</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Monitoring</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Trial meetings</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Quality assurance</span></p> </td> <td style="width: 78.4pt; height: 142.5pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #ACB9CA;" valign="top" width="105"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Statistical analysis plan</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Data validation</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Programming and analysis</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US">  </span></p> </td> <td style="width: 106.45pt; height: 142.5pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #B4C6E7;" valign="top" width="142"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Study Reports</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Data interpretation</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Trial/Study Steering Committee reports</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US">  </span></p> </td> <td style="width: 73.8pt; height: 142.5pt; border-left: medium none; border-right: 1.0pt solid windowtext; border-top: medium none; border-bottom: 1.0pt solid windowtext; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0cm; padding-bottom: 0cm; background: #ACB9CA;" valign="top" width="98"> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> Advice and consulting</span></p> <p class="MsoNormal" style="text-align: justify;"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US"> drafting aspects of the publication</span></p> <p class="MsoNormal"><span style="font-family: Cambria, serif; color: black; font-size: small;" lang="EN-US">  </span></p> </td> </tr> </tbody> </table> </div>  </div></div> Clinical Research Unit 2020-08-20T12:43:01+05:30 2020-08-20T12:43:01+05:30 https://www.nciindia.gov.in/index.php/hi/cru_working-objectives Aman_CF gupta.amn@gmail.com <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p align="center"><span style="font-family: cambria, cambria; font-size: large;"><strong>Working Objectives</strong></span></p> <p><span style="font-family: cambria, cambria; font-size: small;">The CRU team comprising scientists and faculty with varied sets of research skills shall support research investigators (AIIMS faculty and scientists) to design, conduct, analyze, and publish high-quality clinical research. The primary objectives of the CRU shall be the following:</span></p> <p><span style="font-family: cambria, cambria; font-size: small;">Phase I: To provide technical expertise to AIIMS faculty and scientists to plan clinical research proposals and submit grant applications for funding</span></p> <p><span style="font-family: cambria, cambria; font-size: small;">Phase II: To provide support to AIIMS faculty and scientists for conducting research (assisting set-up, the conduct of the study; data management and analysis; report writing; publications)</span></p> </div></div> <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p align="center"><span style="font-family: cambria, cambria; font-size: large;"><strong>Working Objectives</strong></span></p> <p><span style="font-family: cambria, cambria; font-size: small;">The CRU team comprising scientists and faculty with varied sets of research skills shall support research investigators (AIIMS faculty and scientists) to design, conduct, analyze, and publish high-quality clinical research. The primary objectives of the CRU shall be the following:</span></p> <p><span style="font-family: cambria, cambria; font-size: small;">Phase I: To provide technical expertise to AIIMS faculty and scientists to plan clinical research proposals and submit grant applications for funding</span></p> <p><span style="font-family: cambria, cambria; font-size: small;">Phase II: To provide support to AIIMS faculty and scientists for conducting research (assisting set-up, the conduct of the study; data management and analysis; report writing; publications)</span></p> </div></div> Clinical Research Unit 2020-08-20T12:27:05+05:30 2020-08-20T12:27:05+05:30 https://www.nciindia.gov.in/index.php/hi/cru_goal-of-the-clinical-research-unit Aman_CF gupta.amn@gmail.com <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p style="text-align: center;"><span style="font-size: large; font-family: cambria, cambria;"><strong>Goal of the Clinical Research Unit (CRU)</strong> </span></p> <p style="text-align: justify;"><span style="font-family: cambria, cambria; font-size: small;">The overarching goal of the CRU is to provide resources and services to advance clinical research and inform the best practices for clinical research. It will be a core facility with centralizedand shared resources. It shall work as a specialized biomedical research unit that shall help to design and centrally coordinate clinical research by assisting in the development, application, and implementation of investigator-initiatedstudies in compliance with the best practices.</span></p> <p style="text-align: justify;"><span style="font-family: cambria, cambria; font-size: small;">The CRU envisages but is not restricted to the following types of studies: investigator-initiated clinical trials, cohort, case-control, cross-sectional studies as well as the studies evaluating diagnostic tests. The ultimate aim is to facilitate practice-changing research at AIIMS, addressing the critical priorities of the country in disease diagnosis, prevention and treatment.</span></p> </div></div> <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p style="text-align: center;"><span style="font-size: large; font-family: cambria, cambria;"><strong>Goal of the Clinical Research Unit (CRU)</strong> </span></p> <p style="text-align: justify;"><span style="font-family: cambria, cambria; font-size: small;">The overarching goal of the CRU is to provide resources and services to advance clinical research and inform the best practices for clinical research. It will be a core facility with centralizedand shared resources. It shall work as a specialized biomedical research unit that shall help to design and centrally coordinate clinical research by assisting in the development, application, and implementation of investigator-initiatedstudies in compliance with the best practices.</span></p> <p style="text-align: justify;"><span style="font-family: cambria, cambria; font-size: small;">The CRU envisages but is not restricted to the following types of studies: investigator-initiated clinical trials, cohort, case-control, cross-sectional studies as well as the studies evaluating diagnostic tests. The ultimate aim is to facilitate practice-changing research at AIIMS, addressing the critical priorities of the country in disease diagnosis, prevention and treatment.</span></p> </div></div> Clinical Research Unit 2020-08-20T12:21:18+05:30 2020-08-20T12:21:18+05:30 https://www.nciindia.gov.in/index.php/hi/introduction_cru Aman_CF gupta.amn@gmail.com <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p align="center"><span style="font-family: cambria, times; font-size: large;"><strong><span style="font-size: x-large;">Introduction</span> </strong> </span></p> <p style="text-align: justify;"><span style="font-family: cambria, times; font-size: small;">Clinical research forms the cornerstone of evidence-based medicine and advances in clinical practice. An essential component of clinical research is clinical trials, some of which may be multi-centric and engage collaborative efforts. Non-trial clinical research is the other equally important component which helps to understand and answer critical treatment-related questions, identify further research questions, and support development of new biomarkers, etc.There is a need for clinicalresearch designed and led by academic Investigators to address the specific challenges that patients face in India.</span></p> <p style="text-align: justify;"><span style="font-family: cambria, times; font-size: small;">Researchers at AIIMS come with varied scientific backgrounds and levels of exposure. While most are well conversant with the intricacies of research methods, a few may need guidance to develop their idea into a research protocol or to arrange funding or with conduct, analysis, and publication of the study. Also, there is a need to conduct larger studies and trials to make a meaningful impact on the care of patients. In addition, excellent data management and statistical analytical skills are required for optimal utilization of the data generated in various clinical studies.</span></p> <p style="text-align: justify;"><span style="font-family: cambria, times; font-size: small;">The Honourable Vice President Sh. Venkaiah Naidu in his convocation address on 7 Dec 2018 on the occasion of 46th Convocation Day of AIIMS, stressed upon the need for the institute faculty to take clinical research to a higher level and to set up newer mechanisms to foster collaborative research answering translational research issues. The Honourable Vice President urged the AIIMS administration and faculty to launch new initiatives which facilitate clinical research. The administration under the leadership of the honourable Director of AIIMS, Prof. RandeepGuleria and the Dean (Research), Prof. Chitra Sarkar and with the guidance and sage advice of the former Secretary, Department of Biotechnology (DBT) the Late. Prof M.K. Bhan conceptualized and created the Clinical Research Unit (CRU) under the Research Section, AIIMS, New Delhi.</span></p> <p style="text-align: justify;"><span style="font-family: cambria, times; font-size: small;">The Clinical Research Unitshall serve the purpose of improving the quality and quantum of research output through i) Providing high-quality technical expertise in designing clinical research and ii) Providing support for the conduct of studies conforming to international standards.</span></p> </div></div> <div class="feed-description"><div class="content-left-menu">{loadposition CRU_Research}</div> <div class="content-right"> <p align="center"><span style="font-family: cambria, times; font-size: large;"><strong><span style="font-size: x-large;">Introduction</span> </strong> </span></p> <p style="text-align: justify;"><span style="font-family: cambria, times; font-size: small;">Clinical research forms the cornerstone of evidence-based medicine and advances in clinical practice. An essential component of clinical research is clinical trials, some of which may be multi-centric and engage collaborative efforts. Non-trial clinical research is the other equally important component which helps to understand and answer critical treatment-related questions, identify further research questions, and support development of new biomarkers, etc.There is a need for clinicalresearch designed and led by academic Investigators to address the specific challenges that patients face in India.</span></p> <p style="text-align: justify;"><span style="font-family: cambria, times; font-size: small;">Researchers at AIIMS come with varied scientific backgrounds and levels of exposure. While most are well conversant with the intricacies of research methods, a few may need guidance to develop their idea into a research protocol or to arrange funding or with conduct, analysis, and publication of the study. Also, there is a need to conduct larger studies and trials to make a meaningful impact on the care of patients. In addition, excellent data management and statistical analytical skills are required for optimal utilization of the data generated in various clinical studies.</span></p> <p style="text-align: justify;"><span style="font-family: cambria, times; font-size: small;">The Honourable Vice President Sh. Venkaiah Naidu in his convocation address on 7 Dec 2018 on the occasion of 46th Convocation Day of AIIMS, stressed upon the need for the institute faculty to take clinical research to a higher level and to set up newer mechanisms to foster collaborative research answering translational research issues. The Honourable Vice President urged the AIIMS administration and faculty to launch new initiatives which facilitate clinical research. The administration under the leadership of the honourable Director of AIIMS, Prof. RandeepGuleria and the Dean (Research), Prof. Chitra Sarkar and with the guidance and sage advice of the former Secretary, Department of Biotechnology (DBT) the Late. Prof M.K. Bhan conceptualized and created the Clinical Research Unit (CRU) under the Research Section, AIIMS, New Delhi.</span></p> <p style="text-align: justify;"><span style="font-family: cambria, times; font-size: small;">The Clinical Research Unitshall serve the purpose of improving the quality and quantum of research output through i) Providing high-quality technical expertise in designing clinical research and ii) Providing support for the conduct of studies conforming to international standards.</span></p> </div></div>